Novel use of 2-phenyl-substituted imidazotriazinones

Details for Australian Patent Application No. 2002314044 (hide)

Owner Bayer HealthCare AG

Inventors Niewohner, Ulrich; Haning, Helmut; Van Der Staay, Franz, Josef; Rahbar, Afssaneh; Bischoff, Erwin; Barth, Wolfgang; Bandel, Tiemo, Joerg

Agent Davies Collison Cave

Pub. Number AU-B-2002314044

PCT Number PCT/EP02/05002

PCT Pub. Number WO2002/089808

Priority 101 22 576.8 09.05.01 DE; 101 26 198.5 30.05.01 DE

Filing date 7 May 2002

Wipo publication date 18 November 2002

Acceptance publication date 21 September 2006

International Classifications

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 101 22 576.8 09.05.01 DE; 101 26 198.5 30.05.01 DE

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002314044

21 September 2006 Application Accepted

  Published as AU-B-2002314044

18 January 2007 Standard Patent Sealed

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002314045-KNEE ENDOPROTHESIS

2002314043-Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine